These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 23354296

  • 1. Systematic comparison of four cell- and Luminex-based methods for assessment of complement-activating HLA antibodies.
    Lachmann N, Todorova K, Schulze H, Schönemann C.
    Transplantation; 2013 Mar 15; 95(5):694-700. PubMed ID: 23354296
    [Abstract] [Full Text] [Related]

  • 2. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.
    Tait BD, Süsal C, Gebel HM, Nickerson PW, Zachary AA, Claas FH, Reed EF, Bray RA, Campbell P, Chapman JR, Coates PT, Colvin RB, Cozzi E, Doxiadis II, Fuggle SV, Gill J, Glotz D, Lachmann N, Mohanakumar T, Suciu-Foca N, Sumitran-Holgersson S, Tanabe K, Taylor CJ, Tyan DB, Webster A, Zeevi A, Opelz G.
    Transplantation; 2013 Jan 15; 95(1):19-47. PubMed ID: 23238534
    [Abstract] [Full Text] [Related]

  • 3. C1q-fixing human leukocyte antigen assay in immunized renal patients: correlation between Luminex SAB-C1q and SAB-IgG.
    Llorente S, Boix F, Eguia J, López M, Bosch A, Martinez H, Gonzalez MJ, López-Hernández R, Salgado G, Moya-Quiles MR, Campillo JA, García-Alonso AM, Minguela A, Jimeno L, Alvarez-López MR, Muro M.
    Transplant Proc; 2012 Nov 15; 44(9):2535-7. PubMed ID: 23146446
    [Abstract] [Full Text] [Related]

  • 4. [C4d]FlowPRA screening--a specific assay for selective detection of complement-activating anti-HLA alloantibodies.
    Wahrmann M, Exner M, Haidbauer B, Schillinger M, Regele H, Körmöczi G, Böhmig GA.
    Hum Immunol; 2005 May 15; 66(5):526-34. PubMed ID: 15935890
    [Abstract] [Full Text] [Related]

  • 5. Deciphering complement interference in anti-human leukocyte antigen antibody detection with flow beads assays.
    Visentin J, Vigata M, Daburon S, Contin-Bordes C, Fremeaux-Bacchi V, Dromer C, Billes MA, Neau-Cransac M, Guidicelli G, Taupin JL.
    Transplantation; 2014 Sep 27; 98(6):625-31. PubMed ID: 25058376
    [Abstract] [Full Text] [Related]

  • 6. Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads.
    Chen G, Sequeira F, Tyan DB.
    Hum Immunol; 2011 Oct 27; 72(10):849-58. PubMed ID: 21791230
    [Abstract] [Full Text] [Related]

  • 7. Detection of complement-fixing and non-fixing antibodies specific for endothelial precursor cells and lymphocytes using flow cytometry.
    AlMahri A, Holgersson J, Alheim M.
    Tissue Antigens; 2012 Nov 27; 80(5):404-15. PubMed ID: 22931381
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Clinical relevance of preformed C4d-fixing and non-C4d-fixing HLA single antigen reactivity in renal allograft recipients.
    Wahrmann M, Bartel G, Exner M, Regele H, Körmöczi GF, Fischer GF, Böhmig GA.
    Transpl Int; 2009 Oct 27; 22(10):982-9. PubMed ID: 19619171
    [Abstract] [Full Text] [Related]

  • 11. C1q assay for the detection of complement fixing antibody to HLA antigens.
    Chen G, Tyan DB.
    Methods Mol Biol; 2013 Oct 27; 1034():305-11. PubMed ID: 23775744
    [Abstract] [Full Text] [Related]

  • 12. Clinical relevance of complement-fixing antibodies in cardiac transplantation.
    Rose ML, Smith JD.
    Hum Immunol; 2009 Aug 27; 70(8):605-9. PubMed ID: 19375471
    [Abstract] [Full Text] [Related]

  • 13. C4d binding correlated with strong HLA antibodies involved in graft failures.
    Mizutani K, Gotoh M.
    Transplant Proc; 2010 Dec 27; 42(10):4021-5. PubMed ID: 21168616
    [Abstract] [Full Text] [Related]

  • 14. Modified solid-phase alloantibody detection for improved crossmatch prediction.
    Wahrmann M, Hlavin G, Fischer G, Marinova L, Schwaiger E, Hörl WH, Zlabinger GJ, Körmöczi GF, König F, Böhmig GA.
    Hum Immunol; 2013 Jan 27; 74(1):32-40. PubMed ID: 23073293
    [Abstract] [Full Text] [Related]

  • 15. Correlation of Circulating Complement-Fixing Donor-Specific Antibodies Identified by the C1q Assay and Presence of C4d in Endomyocardial Biopsy Specimens.
    Frank R, Lal P, Kearns J, Molina MR, Wald JW, Goldberg LR, Kamoun M.
    Am J Clin Pathol; 2016 Jan 27; 145(1):62-8. PubMed ID: 26712872
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Complement (C1q) fixing solid-phase screening for HLA antibodies increases the availability of compatible platelet components for refractory patients.
    Fontaine MJ, Kuo J, Chen G, Galel SA, Miller E, Sequeira F, Viele M, Goodnough LT, Tyan DB.
    Transfusion; 2011 Dec 27; 51(12):2611-8. PubMed ID: 21615749
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Assignment of C1q-binding HLA antibodies as unacceptable HLA antigens avoids positive CDC-crossmatches prior to transplantation of deceased donor organs.
    Juhl D, Marget M, Hallensleben M, Görg S, Ziemann M.
    Transpl Immunol; 2017 Mar 27; 41():17-21. PubMed ID: 28088367
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.